![MANAGEMENT OF ENDOCRINE DISEASE: Precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives in: European Journal of Endocrinology Volume 181 Issue 1 (2019) MANAGEMENT OF ENDOCRINE DISEASE: Precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives in: European Journal of Endocrinology Volume 181 Issue 1 (2019)](https://d7wqsqjmvtei3.cloudfront.net/view/journals/eje/181/1/images/inline-EJE-19-0021fig1.jpeg)
MANAGEMENT OF ENDOCRINE DISEASE: Precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives in: European Journal of Endocrinology Volume 181 Issue 1 (2019)
![MANAGEMENT OF ENDOCRINE DISEASE: Precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives in: European Journal of Endocrinology Volume 181 Issue 1 (2019) MANAGEMENT OF ENDOCRINE DISEASE: Precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives in: European Journal of Endocrinology Volume 181 Issue 1 (2019)](https://eje.bioscientifica.com/view/journals/eje/181/1/images/EJE-19-0021fig1.jpeg)
MANAGEMENT OF ENDOCRINE DISEASE: Precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives in: European Journal of Endocrinology Volume 181 Issue 1 (2019)
![Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide in: Endocrine-Related Cancer Volume 21 Issue 5 (2014) Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide in: Endocrine-Related Cancer Volume 21 Issue 5 (2014)](https://erc.bioscientifica.com/view/journals/erc/21/5/images/large/705fig3.jpeg)
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide in: Endocrine-Related Cancer Volume 21 Issue 5 (2014)
![Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms - Daskalakis - 2019 - Clinical Endocrinology - Wiley Online Library Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms - Daskalakis - 2019 - Clinical Endocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9f988460-bd33-4d03-8c40-2960bb2b3f9f/cen14055-fig-0004-m.jpg)
Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms - Daskalakis - 2019 - Clinical Endocrinology - Wiley Online Library
![Synchronous tumors of the pancreas and the gallbladder: a case report with targeted NGS evaluation - Sivade - Annals of Translational Medicine Synchronous tumors of the pancreas and the gallbladder: a case report with targeted NGS evaluation - Sivade - Annals of Translational Medicine](https://cdn.amegroups.cn/journals/amepc/files/journals/16/articles/31924/public/31924-PB7-8368-R1.png/w300)
Synchronous tumors of the pancreas and the gallbladder: a case report with targeted NGS evaluation - Sivade - Annals of Translational Medicine
![Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms - Daskalakis - 2019 - Clinical Endocrinology - Wiley Online Library Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms - Daskalakis - 2019 - Clinical Endocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/558ae071-e8ec-4589-a777-29c0b246a282/cen.v91.4.cover.jpg)